Company profile

Company profileOfficial Gazette noticesJapanese original

KalVista Pharmaceuticals Japan株式会社

KalVista Pharmaceuticals Japan株式会社· Corporate Number: 6010601064511

This page aggregates company identity, Official Gazette notices, enforcement records, related-company signals, and source-review links into one public-record profile.

Current page: Company profile

This page brings together Official Gazette notices, enforcement records, registry data, related-company signals, and source-review links for one company. Open individual enforcement records from the history section below.

Public Record Summary

Gazette notices shown here
2
Latest public record
16 Apr 2026

Company Identity and Registry Data

English display name
KalVista Pharmaceuticals Japan株式会社
Original Japanese name
KalVista Pharmaceuticals Japan株式会社
Kana name
かるびすたふぁーましゅーてぃかるずじゃぱん
Corporate Number
6010601064511
Registered address
東京都千代田区丸の内１丁目４番１号丸の内永楽ビルディング２６Ｆ

Note: Detailed gBizINFO registry data may not be available for this company yet. Use the public registry links below to review supplemental source information.

View on gBizINFOView on the National Tax Agency Corporate Number site

gBizINFO: fetched 20 May 2026

Corporate Number site: fetched 20 May 2026

Data sources

Save a record of your review

Keep the records and their sources together

Review what is included, then save the report and CSV in an evidence ZIP for internal sharing. Available source files vary by target.

View this pack's contents — ¥2,980See a free sample (Japanese)

This company: ¥2,980 including tax, one-time purchase. No charge for reviewing the contents. Available files are listed before checkout.

2 records on this page; confirm the delivery scope on the next page.

Four or more packs in a month? Compare Business ・ Already purchased? Sign in

Official Gazette

Japanese Official Gazette company notices

2 notice(s)

Official Gazette company notice

Official Gazette noticeCompany noticeTranslation pending
Publication / issue / page
16 Apr 2026 Extra Edition 第90号 p.53
English summary
Company notice
Published company name
KalVista Pharmaceuticals Japan株式会社
Published address
外） 公 告 会社その他の公告 第2期決算公告 令和8年4月 16 日東京都千代田区丸の内一丁目4番1号丸の内永楽ビルディング26F
Source
Official Gazette
Show original Japanese extracted fields
Original notice type
決算公告
Original related text
第2期決算公告 / 貸借対照表の要旨 (令和7年12月31日現在)
Original excerpt
第2期決算公告 / 貸借対照表の要旨 (令和7年12月31日現在)
Show official Japanese notice text

号外第 ９０ 号 令和８年４月１６日木曜日 官　報 （号　　外） 公　　告 会社その他の公告page="0053"page="0053"　第２期決算公告　　令和８年４月 16 日東京都千代田区丸の内一丁目４番１号丸の内永楽ビルディング26Ｆ　　　　KalVista Pharmaceuticals Japan株式会社代表取締役　沖野　佳秀page="0053"貸借対照表の要旨　　　　(令和７年12月31日現在)科　　　　目金　額(千円)資産　の部　流動資産79,758固定資産11,184繰延資産2,232　　合計　　93,174負債及び　純資産の部流動負債834,763株主資本△741,589資本金5,000利益剰余金△746,589その他利益剰余金△746,589(うち当期純損失)(484,626)　　合計　　93,174©2010独立行政法人国立印刷局/National Printing Bureau. All rights reserved.

Official Gazette company notice

Official Gazette noticeCompany noticeTranslation pending
Publication / issue / page
24 Apr 2025 Extra Edition 第92号 p.71
English summary
Company notice
Published company name
KalVista Pharmaceuticals Japan株式会社
Published address
外） 公 告 会社その他の公告 第1期決算公告 令和7年4月 24 日東京都千代田区丸の内一丁目4番1号丸の内永楽ビルディング26F
Source
Official Gazette
Show original Japanese extracted fields
Original notice type
決算公告
Original related text
第1期決算公告 / 貸借対照表の要旨 (令和6年12月31日現在)
Original excerpt
第1期決算公告 / 貸借対照表の要旨 (令和6年12月31日現在)
Show official Japanese notice text

号外第 ９２ 号 令和７年４月２４日木曜日 官　報 （号　　外） 公　　告 会社その他の公告page="0071"page="0071"　第１期決算公告　　令和７年４月 24 日東京都千代田区丸の内一丁目４番１号丸の内永楽ビルディング26Ｆ　　　　KalVista Pharmaceuticals Japan株式会社代表取締役　沖野　佳秀page="0071"貸借対照表の要旨　　　　(令和６年12月31日現在)科　　　　目金　額(千円)資産の部流動資産104,332固定資産3,405　　合計　　107,737負債及び　純資産の部流動負債364,700株主資本△256,962資本金5,000利益剰余金△261,962その他利益剰余金△261,962(うち当期純損失)(261,962)　　合計　　107,737©2010独立行政法人国立印刷局/National Printing Bureau. All rights reserved.

Language

日本語版を見る (Japanese)

About this English name

No official English name source is recorded. The original Japanese name is shown.

If this profile contains an error or your company needs to add context, please use the correction request form. Submissions are reviewed under RegBase editorial policy.

This page mechanically aggregates and structures public government disclosures and public registry data under the editorial policy. It is not legal advice, credit scoring, or a final procurement decision. Always verify against the official source pages.